Report cover image

Uveitis Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Sep 26, 2024
Length 141 Pages
SKU # PROD19315117

Description

Uveitis Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global uveitis market is expected to grow at a CAGR of around 6.2% during 2025-2034. This report on global uveitis market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global uveitis market by segmenting the market based on treatment type, disease type, cause, distribution channel, and region. Also, detailed profiles of companies operating in the uveitis market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Growing R&D Activities
• Increasing Awareness Levels
• Increasing Number of Trials

Market Challenges

• Lack of Awareness

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Treatment Type

• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Antibiotics
• Antivirals
• Antifungal
• Analgesics

Market by Disease Type

• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Panuveitis

Market by Cause

• Infectious
• Non-infectious

Market by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa

Table of Contents

141 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Uveitis Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Uveitis Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Uveitis Market by Treatment Type
5.1. Introduction
5.2. Corticosteroids
5.3. Immunosuppressant
5.4. Monoclonal Antibodies
5.5. Cycloplegic Agents
5.6. Antibiotics
5.7. Antivirals
5.8. Antifungal
5.9. Analgesics
6. Global Uveitis Market by Disease Type
6.1. Introduction
6.2. Anterior Uveitis
6.3. Posterior Uveitis
6.4. Intermediate Uveitis
6.5. Panuveitis
7. Global Uveitis Market by Cause
7.1. Introduction
7.2. Infectious
7.3. Non-infectious
8. Global Uveitis Market by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Others
9. Global Uveitis Market by Region
9.1 Introduction
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Netherlands
9.2.8 Rest of the Europe
9.3 North America
9.3.1 United States
9.3.2 Canada
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 Indonesia
9.4.7 Rest of the Asia Pacific
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 Turkey
9.6.3 Iran
9.6.4 Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1 Competitive Scenario
13.2 Company Profiles
13.2.1 AbbVie Inc.
13.2.2 Alimera Sciences Inc.
13.2.3 Bausch & Lomb Incorporated (Bausch Health)
13.2.4 Enzo Biochem Inc.
13.2.5 Eyegate Pharmaceuticals Inc.
13.2.6 Eyepoint Pharmaceuticals Inc.
13.2.7 Novartis AG
13.2.8 Regeneron Pharmaceuticals Inc.
13.2.9 Santen Pharmaceutical Co. Ltd.
List of Figures
Figure 1: Global Uveitis Market (in US$ Million), 2020-2024
Figure 2: Global Uveitis Market by Treatment Type, 2024
Figure 3: Global Uveitis Market by Disease Type, 2024
Figure 4: Global Uveitis Market by Cause, 2024
Figure 5: Global Uveitis Market by Distribution Channel, 2024
Figure 6: Global Uveitis Market by Region, 2024
Figure 7: Global Uveitis Market (in US$ Million), 2025-2034
Figure 8: Global Uveitis Market by Treatment Type (in %), 2024 & 2034
Figure 9: Global Corticosteroids Uveitis Market (in US$ Million), 2020-2024
Figure 10: Global Corticosteroids Uveitis Market (in US$ Million), 2025-2034
Figure 11: Global Immunosuppressant Uveitis Market (in US$ Million), 2020-2034
Figure 12: Global Immunosuppressant Uveitis Market (in US$ Million), 2025-2034
Figure 13: Global Monoclonal Antibodies Uveitis Market (in US$ Million), 2020-2034
Figure 14: Global Monoclonal Antibodies Uveitis Market (in US$ Million), 2025-2034
Figure 15: Global Cycloplegic Agents Uveitis Market (in US$ Million), 2020-2034
Figure 16: Global Cycloplegic Agents Uveitis Market (in US$ Million), 2025-2034
Figure 17: Global Antibiotics Uveitis Market (in US$ Million), 2020-2034
Figure 18: Global Antibiotics Uveitis Market (in US$ Million), 2025-2034
Figure 19: Global Antivirals Uveitis Market (in US$ Million), 2020-2034
Figure 20: Global Antivirals Uveitis Market (in US$ Million), 2025-2034
Figure 21: Global Antifungal Uveitis Market (in US$ Million), 2020-2034
Figure 22: Global Antifungal Uveitis Market (in US$ Million), 2025-2034
Figure 23: Global Analgesics Uveitis Market (in US$ Million), 2020-2034
Figure 24: Global Analgesics Uveitis Market (in US$ Million), 2025-2034
Figure 25: Global Uveitis Market by Disease Type (in %), 2024 & 2034
Figure 26: Global Anterior Uveitis Market (in US$ Million), 2020-2024
Figure 27: Global Anterior Uveitis Market (in US$ Million), 2025-2034
Figure 28: Global Posterior Uveitis Market (in US$ Million), 2020-2024
Figure 29: Global Posterior Uveitis Market (in US$ Million), 2025-2034
Figure 30: Global Intermediate Uveitis Market (in US$ Million), 2020-2024
Figure 31: Global Intermediate Uveitis Market (in US$ Million), 2025-2034
Figure 32: Global Panuveitis Uveitis Market (in US$ Million), 2020-2024
Figure 33: Global Panuveitis Uveitis Market (in US$ Million), 2025-2034
Figure 34: Global Uveitis Market by Cause (in %), 2024 & 2034
Figure 35: Global Infectious Uveitis Market (in US$ Million), 2020-2024
Figure 36: Global Infectious Uveitis Market (in US$ Million), 2025-2034
Figure 37: Global Non-Infectious Uveitis Market (in US$ Million), 2020-2034
Figure 38: Global Non-Infectious Uveitis Market (in US$ Million), 2025-2034
Figure 39: Global Uveitis Market by Distribution Channel (in %), 2024 & 2034
Figure 40: Global Hospital Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 41: Global Hospital Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 42: Global Retail Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 43: Global Retail Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 44: Global Online Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 45: Global Online Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 46: Global Others Uveitis Market (in US$ Million), 2020-2034
Figure 47: Global Others Uveitis Market (in US$ Million), 2025-2034
Figure 48: Global Uveitis Market by Region (in %), 2024 & 2034
Figure 49: Europe Uveitis Market (in US$ Million), 2020-2024
Figure 50: Europe Uveitis Market (in US$ Million), 2025-2034
Figure 51: Europe Uveitis Market by Country (in %), 2024 & 2034
Figure 52: Germany Uveitis Market (in US$ Million), 2020-2034
Figure 53: United Kingdom Uveitis Market (in US$ Million), 2020-2034
Figure 54: France Uveitis Market (in US$ Million), 2020-2034
Figure 55: Italy Uveitis Market (in US$ Million), 2020-2034
Figure 56: Spain Uveitis Market (in US$ Million), 2020-2034
Figure 57: Russia Uveitis Market (in US$ Million), 2020-2034
Figure 58: Netherlands Uveitis Market (in US$ Million), 2020-2034
Figure 59: North America Uveitis Market (in US$ Million), 2020-2024
Figure 60: North America Uveitis Market (in US$ Million), 2025-2034
Figure 61: North America Uveitis Market by Country (in %), 2024 & 2034
Figure 62: United States Uveitis Market (in US$ Million), 2020-2034
Figure 63: Canada Uveitis Market (in US$ Million), 2020-2034
Figure 64: Asia Pacific Uveitis Market (in US$ Million), 2020-2024
Figure 65: Asia Pacific Uveitis Market (in US$ Million), 2025-2034
Figure 66: Asia Pacific Uveitis Market by Country (in %), 2024 & 2034
Figure 67: China Uveitis Market (in US$ Million), 2020-2034
Figure 68: Japan Uveitis Market (in US$ Million), 2020-2034
Figure 69: India Uveitis Market (in US$ Million), 2020-2034
Figure 70: South Korea Uveitis Market (in US$ Million), 2020-2034
Figure 71: Australia Uveitis Market (in US$ Million), 2020-2034
Figure 72: Indonesia Uveitis Market (in US$ Million), 2020-2034
Figure 73: Latin America Uveitis Market (in US$ Million), 2020-2024
Figure 74: Latin America Uveitis Market (in US$ Million), 2025-2034
Figure 75: Latin America Uveitis Market by Country (in %), 2024 & 2034
Figure 76: Mexico Uveitis Market (in US$ Million), 2020-2034
Figure 77: Brazil Uveitis Market (in US$ Million), 2020-2034
Figure 78: Argentina Uveitis Market (in US$ Million), 2020-2034
Figure 79: Middle East & Africa Uveitis Market (in US$ Million), 2020-2024
Figure 80: Middle East & Africa Uveitis Market (in US$ Million), 2025-2034
Figure 81: Middle East & Africa Uveitis Market by Country (in %), 2024 & 2034
Figure 82: Saudi Arabia Uveitis Market (in US$ Million), 2020-2034
Figure 83: Turkey Uveitis Market (in US$ Million), 2020-2034
Figure 84: Iran Uveitis Market (in US$ Million), 2020-2034
Figure 85: Market Value Chain
List of Tables
Table 1: Global Uveitis Market Portraiture
Table 2: Global Uveitis Market by Treatment Type (in US$ Million), 2024 & 2034
Table 3: Global Uveitis Market by Disease Type (in US$ Million), 2024 & 2034
Table 4: Global Uveitis Market by Cause (in US$ Million), 2024 & 2034
Table 5: Global Uveitis Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 6: Global Uveitis Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us